Cargando…
Demethyleneberberine Protects against Hepatic Fibrosis in Mice by Modulating NF-κB Signaling
Demethyleneberberine (DMB) is an essential metabolite of Berberine (BBR) in vivo. Recent reports have revealed multiple novel therapeutic applications of BBR. However, the pharmacological activities of DMB remain to be elucidated. This study aimed to demonstrate the hepatoprotective and anti-fibroti...
Autores principales: | Wang, Yongchen, Zhao, Zheng, Yan, Yan, Qiang, Xiaoyan, Zhou, Cuisong, Li, Ruiyan, Chen, Huan, Zhang, Yubin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964412/ https://www.ncbi.nlm.nih.gov/pubmed/27376272 http://dx.doi.org/10.3390/ijms17071036 |
Ejemplares similares
-
Demethyleneberberine alleviated the inflammatory response by targeting MD-2 to inhibit the TLR4 signaling
por: Zhao, Yaxing, et al.
Publicado: (2023) -
Cordycepin Protects against Hepatic Ischemia/Reperfusion Injury via Inhibiting MAPK/NF-κB Pathway
por: Ding, Jiameng, et al.
Publicado: (2022) -
Agaricoglycerides Protect against Hepatic Ischemia/Reperfusion Injury by Attenuating Inflammatory Response, Oxidative Stress, and Expression of NF-κB
por: Zhao, Xiang-qian, et al.
Publicado: (2015) -
Aspirin alleviates hepatic fibrosis by suppressing hepatic stellate cells activation via the TLR4/NF-κB pathway
por: Liu, Yan, et al.
Publicado: (2020) -
Plumbagin protects against hydrogen peroxide-induced neurotoxicity by modulating NF-κB and Nrf-2
por: Kuan-Hong, Wang, et al.
Publicado: (2016)